Search
for
Sort by
Research 421–450 of 899
- Dr. Nishant Chhajer (22/12/1977 - 10/1/2024)
- Human and animal cells under influence of different lighting and stimulus
- Impact of Chemotherapeutic Drug on People living with Cancer
- An Overview of Harmful Effects of Polycystic Ovary Syndrome
- Abstracts Pt.30
- A comparative analysis of three explanatory models of mental disorder and a preferred focus of explanation
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- Vitamin D deficiency in patients with alopecia areata: A systematic review and meta-analysis
- Medicinal value of hibiscus rosa sinensis : a review
- Citrullus colocynthis (L.) Schrad. (Cucurbitaceae)
- The Potential Reversible Transition between Stem Cells and Transient-Amplifying Cells: The Limbal Epithelial Stem Cell Perspective
- INTEGRATIVE APPROACH TO KHALITYA: BRIDGING AYURVEDA AND MODERN SCIENCE
- INTEGRATIVE APPROACH TO KHALITYA: BRIDGING AYURVEDA AND MODERN SCIENCE
- BH08 Unprovoked pulmonary emboli in a patient with alopecia areata treated with ritlecitinib: a case report
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- Dermatological Indications: Alopecia Areata
- Acne Vulgaris with Polycystic Ovarian Syndrome: A Case Report
- Program Pengelolaan Dan Pencegahan Depresi Melalui Pemeriksaan Apolipoprotein A Dan B Pada Kelompok Lanjut Usia
- P88 Real-world evidence on efficacy and safety of Janus Kinase inhibitors in the treatment of moderate to severe active Ulcerative Colitis
- Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
- Observation and consideration on using of JAKi in clinical trials in times of COVID ‐19
- Uloga folikularnih matičnih stanica u patofiziologiji alopecije areate
- Mettl3-catalyzed m <sup>6</sup> A regulates histone modifier and modification expression in self-renewing somatic tissue
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Localization of Plasminogen Activator Inhibitor Type 2 (PAI-2) in Hair and Nail: Implications for Terminal Differentiation
- Vaniqa--eflornithine 13.9% cream.
- Long-term treatment with apremilast in hidradenitis suppurativa: A 2-year follow-up of initial responders
- Under Development JAK Inhibitors for Dermatologic Diseases